L. Roy Papp & Associates’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-36,885
| Closed | -$6.09M | – | 175 |
|
|
2021
Q2 | $6.09M | Sell |
36,885
-4,186
| -10% | -$699K | 0.77% | 35 |
|
|
2021
Q1 | $6.3M | Sell |
41,071
-5,215
| -11% | -$708K | 0.9% | 34 |
|
|
2020
Q4 | $5.81M | Buy |
46,286
+593
| +1% | +$66.3K | 0.67% | 37 |
|
|
2020
Q3 | $4.63M | Sell |
45,693
-764
| -2% | -$77.9K | 0.6% | 40 |
|
|
2020
Q2 | $4.52M | Hold |
46,457
| – | – | 0.64% | 37 |
|
|
2020
Q1 | $3.86M | Buy |
46,457
+382
| +0.8% | +$37.3K | 0.7% | 39 |
|
|
2019
Q4 | $5.12M | Sell |
46,075
-37
| -0.1% | -$3.81K | 0.74% | 37 |
|
|
2019
Q3 | $4.58M | Buy |
46,112
+659
| +1% | +$65.4K | 0.72% | 38 |
|
|
2019
Q2 | $4.51M | Buy |
45,453
+337
| +0.7% | +$32.2K | 0.71% | 39 |
|
|
2019
Q1 | $4.98M | Sell |
45,116
-2,515
| -5% | -$263K | 0.9% | 31 |
|
|
2018
Q4 | $4.38M | Buy |
47,631
+896
| +2% | +$90.7K | 0.92% | 31 |
|
|
2018
Q3 | $5.15M | Buy |
46,735
+750
| +2% | +$78.1K | 0.92% | 30 |
|
|
2018
Q2 | $4.29M | Buy |
45,985
+2,630
| +6% | +$226K | 0.81% | 34 |
|
|
2018
Q1 | $3.6M | Buy |
43,355
+1,750
| +4% | +$155K | 0.69% | 39 |
|
|
2017
Q4 | $3.79M | Sell |
41,605
-1,249
| -3% | -$104K | 0.75% | 33 |
|
|
2017
Q3 | $3.26M | Buy |
42,854
+14,354
| +50% | +$1.08M | 0.71% | 38 |
|
|
2017
Q2 | $2.14M | Buy |
28,500
+9,773
| +52% | +$677K | 0.46% | 52 |
|
|
2017
Q1 | $1.22M | Buy |
18,727
+735
| +4% | +$43.3K | 0.28% | 68 |
|
|
2016
Q4 | $992K | Buy |
+17,992
| New | +$987K | 0.23% | 78 |
|
Other funds holding PRAH
L. Roy Papp & Associates's PRAH Position: Q3 2021 in Review
L. Roy Papp & Associates sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 36,885 shares — an estimated $6.09M sold.
L. Roy Papp & Associates first reported a position in PRAH in Q4 2016 and held it in 19 quarters. The position peaked at $6.3M in Q1 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- L. Roy Papp & Associates reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- L. Roy Papp & Associates sold 36,885 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $6.09M.
- L. Roy Papp & Associates first reported a position in PRA Health Sciences, Inc. in Q4 2016 and held it in 19 quarters.
- L. Roy Papp & Associates's PRA Health Sciences, Inc. position peaked at $6.3M in Q1 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on L. Roy Papp & Associates's 13F filing for Q3 2021, filed 9 Nov 2021.